Patrik Renblad

Patrik Renblad

Direttore Finanziario/CFO presso CANTARGIA AB

54 anni
Health Technology
Consumer Services

Provenienza dei contatti di primo grado di Patrik Renblad

EntitàTipo di entitàSettore Industriale
Public Company Pharmaceuticals: Major 12
Public Company Pharmaceuticals: Major 5

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Patrik Renblad tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
CHEMOMETEC A/S Medical Specialties

Jeppe Øvlesen

Chief Executive Officer

SGS SA Miscellaneous Commercial Services

Thierry Duvauchelle

Corporate Officer/Principal

ACTIVE BIOTECH AB Biotechnology

Göran Forsberg

David Liberg

Investor Relations Contact

Corporate Officer/Principal

VITROLIFE AB Medical Specialties

Magnus Nilsson

Chief Executive Officer

RAYSEARCH LABORATORIES AB Packaged Software

Anders Martin-Löf

Director of Finance/CFO

Pharmaceuticals: Major

Anders Martin-Löf

Director/Board Member

University of Hartford College/University

Jeppe Øvlesen

Masters Business Admin

ONCOPEPTIDES AB Pharmaceuticals: Major

Anders Martin-Löf

Director of Finance/CFO

CAMURUS AB Pharmaceuticals: Major

Liselotte Larsson

Corporate Officer/Principal

Royal Institute of Technology College/University

Anders Martin-Löf

Graduate Degree

University of Lund College/University

Liselotte Larsson

Nedjad Losic

Doctorate Degree

Graduate Degree

ENSIMAG College/University

Anders Martin-Löf

Graduate Degree

Packaged Software

Jeppe Øvlesen

Founder

Packaged Software

Jeppe Øvlesen

Founder

Università degli Studi di Modena e Reggio Emilia College/University

Flavia Borellini

Doctorate Degree

Information Technology Services

Anders Martin-Löf

Director of Finance/CFO

SWEDISH ORPHAN BIOVITRUM AB Pharmaceuticals: Major

Anders Martin-Löf

Investor Relations Contact

MENDUS AB Biotechnology

Magnus Nilsson

Gunnar Magnus Modee Persson

Director/Board Member

Director/Board Member

PNN Medical A/S

Jeppe Øvlesen

Chief Executive Officer

WILSON THERAPEUTICS AB Pharmaceuticals: Major

Anders Martin-Löf

Director of Finance/CFO

Vingmed Danmark A/S

Jeppe Øvlesen

Corporate Officer/Principal

Enovacor ApS

Jeppe Øvlesen

Director/Board Member

Vikarbasen A/S

Jeppe Øvlesen

Chairman

PNN Medical SA

Jeppe Øvlesen

Chief Executive Officer

Sundialog A/S

Jeppe Øvlesen

Director/Board Member

Packaged Software

Jeppe Øvlesen

Chairman

Medical Specialties

Jeppe Øvlesen

Chairman

CERENO SCIENTIFIC AB Pharmaceuticals: Major

Jeppe Øvlesen

Director/Board Member

Oncopeptides Incentive AB

Anders Martin-Löf

Director/Board Member

Sciencecap Stockholm AB

Anders Martin-Löf

Director/Board Member

Corporate Culture ApS

Jeppe Øvlesen

Corporate Officer/Principal

MONSENSO A/S Internet Software/Services

Jeppe Øvlesen

Director/Board Member

Pharmaceuticals: Major

Henrik Stage

Jeppe Øvlesen

Director/Board Member

Director/Board Member

Quantass ApS

Jeppe Øvlesen

Corporate Officer/Principal

Miscellaneous Commercial Services

Damian Marron

Chairman

Packaged Software

Damian Marron

Chairman

Lisa Martin-Löf Konsultbyrå AB

Anders Martin-Löf

Director/Board Member

Pharmaceuticals: Major

Bengt Jöndell

Corporate Officer/Principal

Information Technology Services

Jeppe Øvlesen

Chief Executive Officer

Miscellaneous Commercial Services

Jeppe Øvlesen

Director/Board Member

Industrial Machinery

Jeppe Øvlesen

Director/Board Member

Treehill Partners, LLC

Damian Marron

Corporate Officer/Principal

Perfusion Tech ApS

Jeppe Øvlesen

Director/Board Member

Medical Specialties

Jeppe Øvlesen

Chairman

Biotechnology

Damian Marron

Chairman

TXP Pharma GmbH

Jeppe Øvlesen

Chief Executive Officer

Statistiche

Distribuzione geografica

Danimarca 23
Svezia 19
Regno Unito 4
Stati Uniti 3
Svizzera 2

Settori

Health Technology 17
Technology Services 9
Consumer Services 6
Commercial Services 5
Utilities 2

Posizioni

Director/Board Member 80
Corporate Officer/Principal 34
Chairman 30
Chief Executive Officer 22
Independent Dir/Board Member 19
-40% Proroga eccezionale: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA